Reliq Health Technologies, Inc. Announces Agreements to Add over 10,000 Musculoskeletal and Respiratory Condition Patients in 2022
February 15 2022 - 3:01AM
Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or
WKN:A2AJTB) (“
Reliq” or the
“
Company”), a rapidly growing global healthcare
technology company that develops innovative Virtual Care solutions
for the multi-billion dollar Healthcare market, today announced
that it has signed implementation plan agreements with current
clients that are expected to add over 10,000 new patients to the
platform this year, leveraging the new Medicare Remote Therapeutic
Monitoring billing codes for patients with musculoskeletal or
respiratory conditions.
“As previously disclosed, for 2022 the Centers
for Medicare and Medicaid Services (CMS) have expanded their
virtual care reimbursement programs to include Remote Therapeutic
Monitoring (RTM),” said Dr. Lisa Crossley, CEO of Reliq Health
Technologies, Inc. “Five new billing codes for RTM were introduced
on January 1, 2022. This is consistent with the trend CMS has
established over the past four years towards increased
reimbursement for virtual care programs that can decrease
healthcare costs by reducing hospitalizations and ER visits. Remote
Therapeutic Monitoring allows clinicians to provide ongoing in-home
treatment and monitoring for patients with musculoskeletal and
respiratory conditions. RTM involves having patients use medical
devices that collect non-physiological data such as
therapy/medication adherence and therapy/medication response, and
also allows for patient self-reporting of key metrics such as pain
level, mobility, nighttime waking due to breathing difficulties,
etc. The new RTM codes have increased the eligible patient
population for our primary care clients by over 50% and allow
orthopaedic and respiratory specialists to use Reliq’s iUGO Care
platform to improve patient care and generate new revenue streams
for their specialty practices. The new RTM codes have increased
Reliq’s target patient population by over 20 million eligible
patients. We expect to begin onboarding RTM patients with our
existing clients later this month. Based on current implementation
plans we expect to add a minimum of 10,000 new RTM patients this
year through our current clients alone at an average revenue of $40
per patient per month.”
Reliq HealthReliq Health
Technologies is a rapidly growing global healthcare technology
company that specializes in developing innovative Virtual Care
solutions for the multi-billion dollar Healthcare market. Reliq’s
powerful iUGO Care platform supports care coordination and
community-based virtual healthcare. iUGO Care allows complex
patients to receive high quality care at home, improving health
outcomes, enhancing quality of life for patients and families and
reducing the cost of care delivery. iUGO Care provides real-time
access to remote patient monitoring data, allowing for timely
interventions by the care team to prevent costly hospital
readmissions and ER visits. Reliq Health Technologies trades on the
TSX Venture under the symbol RHT, on the OTC as RQHTF and on the
WKN as A2AJTB.
ON BEHALF OF THE BOARD“Dr. Lisa Crossley”CEO and Director
For further information please contact:
Company ContactInvestor Relations
at ir@reliqhealth.com
US Investor Relations ContactInvestor
RelationsLytham Partners, LLCBen ShamsianNew York |
Phoenix646-829-9701shamsian@lythampartners.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward
Looking Information
Certain statements in this press release
constitute forward-looking statements, within the meaning of
applicable securities laws. All statements that are not historical
facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives,
assumptions, expectations or beliefs of future performance, are
"forward-looking statements".
We caution you that such "forward-looking
statements" involve known and unknown risks and uncertainties that
could cause actual and future events to differ materially from
those anticipated in such statements.
Forward-looking statements include, but are not
limited to, statements with respect to commercial operations,
including technology development, anticipated revenues, projected
size of market, and other information that is based on forecasts of
future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the
"Company") does not intend and does not assume any
obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology
development and marketing activities, the Company's historical
experience with technology development, uninsured risks. Actual
results may differ materially from those expressed or implied by
such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies (TSXV:RHT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Reliq Health Technologies (TSXV:RHT)
Historical Stock Chart
From Apr 2023 to Apr 2024